CELLOMICS INC
S-1/A, EX-27.1, 2000-11-16
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CELLOMICS INC, S-1/A, EX-27, 2000-11-16
Next: QUEPASA COM INC, 424B3, 2000-11-16



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM OUR
FINANCIAL STATEMENTS AS OF AND FOR THE YEAR ENDED DECEMBER 31, 1999 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<RESTATED>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                       1,341,333
<SECURITIES>                                         0
<RECEIVABLES>                                1,572,282
<ALLOWANCES>                                         0
<INVENTORY>                                    224,536
<CURRENT-ASSETS>                             3,473,372
<PP&E>                                       3,109,462
<DEPRECIATION>                                 722,907
<TOTAL-ASSETS>                               5,859,927
<CURRENT-LIABILITIES>                        4,696,374
<BONDS>                                              0
                       12,152,654
                                          0
<COMMON>                                        37,779
<OTHER-SE>                                (15,771,426)
<TOTAL-LIABILITY-AND-EQUITY>                 5,859,927
<SALES>                                      1,350,041
<TOTAL-REVENUES>                             3,390,451
<CGS>                                          404,785
<TOTAL-COSTS>                               13,847,649
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             302,040
<INCOME-PRETAX>                           (10,617,803)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (10,617,803)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (10,617,803)
<EPS-BASIC>                                     (3.06)
<EPS-DILUTED>                                   (3.06)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission